Cargando…
Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?
Cardiovascular diseases (CVDs) are a leading cause of death globally. This article explores the evidence surrounding community pharmacist interventions to reduce cardiovascular events and related mortality and to improve the management of CVD risk factors. We summarize a range of systematic reviews...
Autores principales: | Mc Namara, Kevin, Alzubaidi, Hamzah, Jackson, John Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366352/ https://www.ncbi.nlm.nih.gov/pubmed/30788283 http://dx.doi.org/10.2147/IPRP.S133088 |
Ejemplares similares
-
Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study
por: Alzubaidi, Hamzah Tareq, et al.
Publicado: (2019) -
Psychometric properties of the Arabic version of the 9-item Shared Decision-Making Questionnaire: the entire process from translation to validation
por: Alzubaidi, Hamzah, et al.
Publicado: (2019) -
Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study
por: Mc Namara, Kevin P, et al.
Publicado: (2010) -
Getting it Done: How to Lead when you're not in Charge
por: Fisher, Roger, et al.
Publicado: (1998) -
Getting the LV lead to the right spot
por: Jackson, K.P., et al.
Publicado: (2015)